Racial and Ethnic Differences in Inpatient Palliative Care for Pediatric Stem Cell Transplant Patients*. Issue 6 (22nd February 2022)

• Record Type: Journal Article
• Authors: McKee, Maya N.; Palama, Brett K.; Hall, Matt; LaBelle, James L.; Bohr, Nicole L.; Hoehn, K. Sarah
• Is Part Of: Pediatric critical care medicine. Volume 23:Issue 6(2022)
• Page Start: 417
• Page End: 424
• Publication Date: 2022-02-22
• Subjects: end-of-life care -- healthcare disparities -- hematopoietic stem cell transplantation -- palliative care -- pediatrics -- race; Pediatric intensive care -- Periodicals; Pediatric emergencies -- Periodicals; 618.05
• DOI: 10.1097/PCC.0000000000002916
• Languages: English
• ISSNs: 1529-7535

Abstract

Abstract : OBJECTIVES: Racial/ethnic disparities in utilizing inpatient palliative care services are well documented in the adult literature. However, the impact of racial/ethnic disparities in the context of pediatric palliative care is less well understood even in high-acuity patient populations such as stem cell transplant patients. We investigated racial/ethnic differences in the utilization of inpatient palliative care consultations (IPCCs) for pediatric stem cell transplant patients. STUDY DESIGN: A retrospective cohort study was conducted using the Pediatric Health Information System database. A generalized linear mixed effects model was developed to assess demographic and clinical characteristics associated with the likelihood of receiving IPCC. SETTING: Thirty-eight tertiary pediatric hospitals in the United States. PATIENTS: Pediatric patients undergoing stem cell transplantation for any indication from January 2017 to December 2019. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Of the 1, 193 inpatient encounters studied, 12% ( n = 143) included a palliative care consult. IPCC rates varied across hospitals with a median rate of 5.97% (interquartile range, 0.00–20.71). In multivariable analyses, Hispanic/Latinx patients were 59% less likely to receive IPCC compared with non-Hispanic White patients (odds ratio [OR], 0.41; 95% CI, 0.21–0.78). This difference persisted after adjusting for all other sociodemographic and clinical factors. In terms of the other clinical characteristics, having a malignant condition and mechanical ventilation were associated with significantly increased odds of receiving IPCC for the entire cohort (OR Malignancy: 1.93; 95% CI: 1.07-3.51; OR Mechanical Ventilation: 2.37; 95% CI: 1.36-4.13). The remainder of the variables were not found to be significantly associated with IPCC. CONCLUSIONS: Racial and ethnic differences exist in the likelihood of receiving palliative care consultations among hospitalized pediatric stem cell transplant recipients. Evaluating the impact of systemic racism and social determinants on palliative care medicine as well as standardizing early integration of IPCC may potentially mitigate disparities in this population.